Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margot Thiaucourt

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Vaccines|March 30, 2023
Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA VaccinesCatharina Gerhards, Margot Thiaucourt, Michael Hetjens, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 12, 2020
Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samplesVerena Haselmann, Maximilian Kittel, Catharina Gerhards, et al.
Neuroscience|October 6, 2017
Posterior Insular GABA Levels Inversely Correlate with the Intensity of Experimental Mechanical Pain in Healthy SubjectsMargot Thiaucourt, Polina Shabes, Natalie Schloss, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 12, 2021
Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassayMaximilian Kittel, Peter Findeisen, Maria-Christina Muth, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 1, 2021
Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infectionCatharina Gerhards, Margot Thiaucourt, Maximilian Kittel, et al.
Cancers|July 13, 2024
C-Reactive Protein Kinetic as a Potential Predictive and Prognostic Factor during Treatment with Checkpoint Inhibitors in R/M-HNSCCFrederic Jungbauer, Claudia Scherl, Nicole Rotter, et al.
Life (Basel, Switzerland)|July 27, 2022
Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening ConditionsFrederic Jungbauer, Catharina Gerhards, Margot Thiaucourt, et al.
Viruses|February 28, 2023
Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-SyndromeCatharina Gerhards, Maximilian Kittel, Volker Ast, et al.
Clinical Laboratory|December 15, 2021
SARS-CoV-2 Antibody Testing - How to Increase the Positive Predictive ValueMargot Thiaucourt, Catharina Gerhards, Maximilian Kittel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2020
Clinical evaluation of commercial automated SARS-CoV-2 immunoassaysMaximilian Kittel, Maria Christina Muth, Ingrid Zahn, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Vaccines|March 30, 2023
Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA VaccinesCatharina Gerhards, Margot Thiaucourt, Michael Hetjens, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 12, 2020
Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samplesVerena Haselmann, Maximilian Kittel, Catharina Gerhards, et al.
Neuroscience|October 6, 2017
Posterior Insular GABA Levels Inversely Correlate with the Intensity of Experimental Mechanical Pain in Healthy SubjectsMargot Thiaucourt, Polina Shabes, Natalie Schloss, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 12, 2021
Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassayMaximilian Kittel, Peter Findeisen, Maria-Christina Muth, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 1, 2021
Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infectionCatharina Gerhards, Margot Thiaucourt, Maximilian Kittel, et al.
Cancers|July 13, 2024
C-Reactive Protein Kinetic as a Potential Predictive and Prognostic Factor during Treatment with Checkpoint Inhibitors in R/M-HNSCCFrederic Jungbauer, Claudia Scherl, Nicole Rotter, et al.
Life (Basel, Switzerland)|July 27, 2022
Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening ConditionsFrederic Jungbauer, Catharina Gerhards, Margot Thiaucourt, et al.
Viruses|February 28, 2023
Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-SyndromeCatharina Gerhards, Maximilian Kittel, Volker Ast, et al.
Clinical Laboratory|December 15, 2021
SARS-CoV-2 Antibody Testing - How to Increase the Positive Predictive ValueMargot Thiaucourt, Catharina Gerhards, Maximilian Kittel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2020
Clinical evaluation of commercial automated SARS-CoV-2 immunoassaysMaximilian Kittel, Maria Christina Muth, Ingrid Zahn, et al.
Pageof 2